Bayer AG (BAYRY)
7.04
-0.02
(-0.21%)
USD |
OTCM |
Apr 18, 16:00
Bayer Total Liabilities (Quarterly): 91.95B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 91.95B |
| September 30, 2023 | 88.59B |
| June 30, 2023 | 91.88B |
| March 31, 2023 | 91.64B |
| December 31, 2022 | 92.17B |
| September 30, 2022 | 88.01B |
| June 30, 2022 | 94.63B |
| March 31, 2022 | 98.41B |
| December 31, 2021 | 98.59B |
| September 30, 2021 | 98.91B |
| June 30, 2021 | 99.78B |
| March 31, 2021 | 98.48B |
| December 31, 2020 | 105.94B |
| September 30, 2020 | 103.37B |
| June 30, 2020 | 98.75B |
| March 31, 2020 | 84.59B |
| December 31, 2019 | 88.20B |
| September 30, 2019 | 92.58B |
| June 30, 2019 | 94.87B |
| March 31, 2019 | 92.22B |
| December 31, 2018 | 92.18B |
| September 30, 2018 | 91.84B |
| June 30, 2018 | 103.26B |
| March 31, 2018 | 45.63B |
| December 31, 2017 | 45.86B |
| Date | Value |
|---|---|
| September 30, 2017 | 46.48B |
| June 30, 2017 | 53.94B |
| March 31, 2017 | 52.57B |
| December 31, 2016 | 53.22B |
| September 30, 2016 | 58.05B |
| June 30, 2016 | 57.22B |
| March 31, 2016 | 58.77B |
| December 31, 2015 | 52.99B |
| September 30, 2015 | 58.39B |
| June 30, 2015 | 59.67B |
| March 31, 2015 | 59.32B |
| December 31, 2014 | 60.82B |
| September 30, 2014 | 51.17B |
| June 30, 2014 | 48.29B |
| March 31, 2014 | 48.64B |
| December 31, 2013 | 42.13B |
| September 30, 2013 | 42.84B |
| June 30, 2013 | 43.88B |
| March 31, 2013 | 42.40B |
| December 31, 2012 | 43.33B |
| September 30, 2012 | 44.08B |
| June 30, 2012 | 42.03B |
| March 31, 2012 | 45.60B |
| December 31, 2011 | 43.38B |
| September 30, 2011 | 44.70B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
84.59B
Minimum
Mar 2020
105.94B
Maximum
Dec 2020
94.81B
Average
94.63B
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 7.107B |
| Affimed NV | 43.50M |
| InflaRx NV | 19.48M |
| MorphoSys AG | 2.186B |
| BioNTech SE | 3.051B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 128.51B |
| Shareholders Equity (Quarterly) | 36.40B |
| Debt to Equity Ratio | 1.264 |
| Current Ratio | 1.275 |
| Net Debt Paydown Yield | -25.38% |